These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24452907)

  • 1. How "drug-like" are naturally occurring anti-cancer compounds?
    Ntie-Kang F; Lifongo LL; Judson PN; Sippl W; Efange SM
    J Mol Model; 2014 Jan; 20(1):2069. PubMed ID: 24452907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in silico evaluation of the ADMET profile of the StreptomeDB database.
    Ntie-Kang F
    Springerplus; 2013; 2():353. PubMed ID: 23961417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do Drug-likeness Rules Apply to Oral Prodrugs?
    Protti ÍF; Rodrigues DR; Fonseca SK; Alves RJ; de Oliveira RB; Maltarollo VG
    ChemMedChem; 2021 May; 16(9):1446-1456. PubMed ID: 33471444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential of anti-malarial compounds derived from African medicinal plants, part III: an in silico evaluation of drug metabolism and pharmacokinetics profiling.
    Onguéné PA; Ntie-Kang F; Mbah JA; Lifongo LL; Ndom JC; Sippl W; Mbaze LM
    Org Med Chem Lett; 2014 Dec; 4(1):6. PubMed ID: 26548985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in Molecular Properties, Bioavailability, and Permeability across the Bayer Compound Collection.
    O' Donovan DH; De Fusco C; Kuhnke L; Reichel A
    J Med Chem; 2023 Feb; 66(4):2347-2360. PubMed ID: 36752336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the novel heterocyclic derivatives as lead molecules for design and development of potent anticancer agents.
    Azad I; Nasibullah M; Khan T; Hassan F; Akhter Y
    J Mol Graph Model; 2018 May; 81():211-228. PubMed ID: 29609141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer-aided drug design and virtual screening of targeted combinatorial libraries of mixed-ligand transition metal complexes of 2-butanone thiosemicarbazone.
    Khan T; Ahmad R; Azad I; Raza S; Joshi S; Khan AR
    Comput Biol Chem; 2018 Aug; 75():178-195. PubMed ID: 29883916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theoretical evaluation of ADMET properties for coumarin derivatives as compounds with therapeutic potential.
    Żołek T; Maciejewska D
    Eur J Pharm Sci; 2017 Nov; 109():486-502. PubMed ID: 28867490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural compounds as potential Hsp90 inhibitors for breast cancer-Pharmacophore guided molecular modelling studies.
    Rampogu S; Parate S; Parameswaran S; Park C; Baek A; Son M; Park Y; Park SJ; Lee KW
    Comput Biol Chem; 2019 Dec; 83():107113. PubMed ID: 31493740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic profiling of anticancer phytocompounds using computational approach.
    Sharma A; Sharma S; Gupta M; Fatima S; Saini R; Agarwal SM
    Phytochem Anal; 2018 Nov; 29(6):559-568. PubMed ID: 29667756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AfroDb: a select highly potent and diverse natural product library from African medicinal plants.
    Ntie-Kang F; Zofou D; Babiaka SB; Meudom R; Scharfe M; Lifongo LL; Mbah JA; Mbaze LM; Sippl W; Efange SM
    PLoS One; 2013; 8(10):e78085. PubMed ID: 24205103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Property distribution of drug-related chemical databases.
    Oprea TI
    J Comput Aided Mol Des; 2000 Mar; 14(3):251-64. PubMed ID: 10756480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of non-hydroxamate scaffolds against HDAC6 inhibition: A pharmacophore modeling, molecular docking, and molecular dynamics simulation approach.
    Zeb A; Park C; Son M; Rampogu S; Alam SI; Park SJ; Lee KW
    J Bioinform Comput Biol; 2018 Jun; 16(3):1840015. PubMed ID: 29945500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the Physicochemical Properties of Acaricides Based on Lipinski's Rule of Five.
    Chen X; Li H; Tian L; Li Q; Luo J; Zhang Y
    J Comput Biol; 2020 Sep; 27(9):1397-1406. PubMed ID: 32031890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Docking of Phytochemicals Targeting GFRs as Therapeutic Sites for Cancer: an In Silico Study.
    Mendie LE; Hemalatha S
    Appl Biochem Biotechnol; 2022 Jan; 194(1):215-231. PubMed ID: 34988844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico identification of natural products with anticancer activity using a chemo-structural database of Brazilian biodiversity.
    Galúcio JM; Monteiro EF; de Jesus DA; Costa CH; Siqueira RC; Santos GBD; Lameira J; Costa KSD
    Comput Biol Chem; 2019 Dec; 83():107102. PubMed ID: 31487609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico drug metabolism and pharmacokinetic profiles of natural products from medicinal plants in the Congo basin.
    Ntie-Kang F; Lifongo LL; Mbah JA; Owono Owono LC; Megnassan E; Mbaze LM; Judson PN; Sippl W; Efange SM
    In Silico Pharmacol; 2013; 1():12. PubMed ID: 25505657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of blockbuster drugs under the rule-of-five.
    Giménez BG; Santos MS; Ferrarini M; Fernandes JP
    Pharmazie; 2010 Feb; 65(2):148-52. PubMed ID: 20225662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoxygenase directed anti-inflammatory and anti-cancerous secondary metabolites: ADMET-based screening, molecular docking and dynamics simulation.
    Singh S; Awasthi M; Pandey VP; Dwivedi UN
    J Biomol Struct Dyn; 2017 Feb; 35(3):657-668. PubMed ID: 26942689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the pharmacokinetic profile of the CamMedNP natural products database: an in silico approach.
    Ntie-Kang F; Mbah JA; Lifongo LL; Owono Owono LC; Megnassan E; Meva'a Mbaze L; Judson PN; Sippl W; Efange SM
    Org Med Chem Lett; 2013 Aug; 3(1):10. PubMed ID: 24229455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.